Stocks and Investing Stocks and Investing
Tue, March 7, 2017

Joseph Pantginis Reiterated (TGTX) at Strong Buy and Held Target at $18 on, Mar 7th, 2017


Published on 2024-10-25 20:26:20 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $18 on, Mar 7th, 2017.

Joseph has made no other calls on TGTX in the last 4 months.



There is 1 other peer that has a rating on TGTX. Out of the 1 peers that are also analyzing TGTX, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Jason Wittes of "Aegis Capital" Initiated at Strong Buy and Held Target at $26 on, Wednesday, February 22nd, 2017

Contributing Sources